申请人:ImmuneSensor Therapeutics, Inc.
公开号:US20220340613A1
公开(公告)日:2022-10-27
Disclosed are cyclic-di-nucleotide cGAMP analogs, methods of synthesizing the compounds, pharmaceutical compositions comprising the compounds thereof, and use of compounds and compositions in medical therapy.